To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.
For more information about any of our clinical trials, please email [email protected] or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)
Testing low dose tamoxifen for invasive breast cancer (LoTam)
Principal Investigator(s): Christy Morrissey, MD
Status: Open and enrolling
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
Principal Investigator(s): Eleonora Teplinsky, MD
Status: Open and enrolling
A study to examine mindfulness training to improve mental health and well-being in younger breast cancer survivors.
Principal Investigator(s): Eleonora Teplinsky, MD
Status: Open and enrolling
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy
Principal Investigator(s): Eleonora Teplinsky, MD
Status: Open and enrolling
A phase IIIb study to characterize the efficacy and safety of Adjuvant ribociclib plus endocrine therapy in a close-to-clinical practice patient population with HR+ HER2- early breast cancer (Adjuvant WIDER)
Principal Investigator(s): Amanda J. Podolski, MD
Status: Open and enrolling